Insider sales are trivial relative to market cap and follow typical post-vesting patterns. No bearish signal. Monitor next earnings (likely late June) for any fundamental changes; this cluster alone does not warrant action.
Price Chart
Executive Summary
Three C-suite insiders at Nurix Therapeutics sold a total of $415K in open-market shares over a 7-day window, with the CFO and Chief Legal Officer accounting for the bulk of the sales. The cluster represents ~0.02% of the $1.8B market cap, which is trivial in proportion and likely reflects routine portfolio diversification or tax planning rather than a negative signal on fundamentals.
Key Financial Metrics
Key Facts
- CFO Hans van Houte sold $263K (13,473 shares at $16.58) on May 5 and April 30
- Chief Legal Officer Christine Ring sold $282K (8,148 shares at $16.96) on May 4 and April 30
- Chief Scientific Officer Gwenn Hansen sold $53K (3,214 shares at $16.65) on April 30
- Total open-market sales: $598K across 3 insiders; non-cash derivative exercises (6,000 shares at $0) have no economic impact
- Sales represent ~0.03% of NRIX's $1.8B market cap — well below the 0.1% materiality threshold
- All sales occurred at prices near $16.60, within the stock's recent range; no clustering at a peak
Financial Impact
$598K in total open-market sales, ~0.03% of market cap — immaterial
Risk Factors
- Insider sales could accelerate if upcoming clinical data disappoints
- Stock is in a volatile biotech sector; any negative catalyst could amplify selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NRIX-1778025250503 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 29d ago | Insider Cluster | $25.32 $25.10 | ▼ −0.87% | ▲ +0.28% | $22.99 (−9.20%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.22 $27.19 | ▲ +7.81% | ▲ +6.60% | $22.99 (−8.84%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.99 (−8.48%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.99 (−8.48%) |
Aug 3, 2026 8w ago | Insider Cluster | $24.69 $25.96 | ▲ +5.14% | ▲ +5.24% | $22.99 (−6.89%) |
Jul 30, 2026 9w ago | Insider Cluster | $23.21 $25.53 | ▲ +10.00% | ▲ +6.48% | $22.99 (−0.95%) |
Jul 9, 2026 12w ago | Press Release | $23.06 $23.07 | ▲ +0.04% | ▲ +0.60% | $22.99 (−0.30%) |
Jul 2, 2026 13w ago | Insider Cluster | $23.97 $24.69 | ▲ +3.00% | ▲ +2.07% | $22.99 (−4.09%) |
Jun 11, 2026 16w ago | Institutional Cluster | $16.98 $17.12 | ▲ +0.82% | ▲ +0.39% | $22.99 (+35.39%) |
Jun 8, 2026 16w ago | 8-K | $15.64 $17.04 | ▲ +8.95% | ▲ +6.84% | $22.99 (+46.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access